(Q47218031)

11 January 2018

title

Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries (English)

1 reference

11 January 2018

author name string

Ashraf A Basuni

1

1 reference

11 January 2018

Lesley Butterworth

2

1 reference

11 January 2018

G Cooksley

3

1 reference

11 January 2018

S Locarnini

4

1 reference

11 January 2018

W F Carman

5

1 reference

11 January 2018

language of work or name

English

0 references

publication date

1 July 2004

1 reference

11 January 2018

number of pages

9

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

11 January 2018

volume

22

1 reference

11 January 2018

issue

21-22

1 reference

11 January 2018

page(s)

2791-2799

1 reference

11 January 2018

Hepatitis B virus infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Strategies to prevent and control hepatitis B and C virus infections: a global perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Hepatitis B epidemiology in Asia, the Middle East and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Vertical Transmission of Hepatitis B Antigen in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Control of HBV and HDV infection in an isolated Pacific Island: 1. Pattern of infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Seroepidemiology of hepatitis B virus infection in children: Ten years of mass vaccination in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Vaccine-induced escape mutant of hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

A novel hepatitis B virus variant in the sera of immunized children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

An efficient extraction method from blood clots for studies requiring both host and viral DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Genetic prediction of nonresponse to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Class II HLA alleles and hepatitis B virus persistence in African Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Detection of Hepatitis B Surface Gene Mutation in Carrier Children with or without Immunoprophylaxis at Birth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Immunoselected hepatitis B virus mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Hepatitis B virus surface mutations associated with infection after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.01.046

10.1016/J.VACCINE.2004.01.046

7 January 2021

Identifiers

DOI

1 reference

11 January 2018

PubMed ID

15246613

1 reference

11 January 2018